Method and system for manufacturing of biopharmaceutical products

1. A volume tailorable manufacturing system for quality assured manufacturing of biopharmaceutical products associated with a biosafety level classification, the volume tailorable manufacturing system comprising one or more multi-product suites and a control facility configured to control a unidirectional flow in a circulation system of the one or more multi-product suites;

wherein the circulation system is configured to interconnect the one or more multi-product suites and wherein the circulation system comprises separated supply and return systems, the supply system comprising at least one inlet, the return system comprising at least one outlet that is paired with the inlet; and

wherein the supply system is configured as a central spine within a center portion of the volume tailorable manufacturing system and being at least partly enclosed by the one or more multi-product suites.

2. The volume tailorable manufacturing system of claim 1 , wherein each inlet/outlet pair is prepared for connection to a further inlet/outlet pair of a further multi-product suite and wherein a seal of an inlet/outlet pair is configured to be broken to expand the volume tailorable manufacturing system with the further multi-product suite.

3. The volume tailorable manufacturing system of claim 1 , wherein the or each inlet/outlet pair is prepared for connection to a further inlet/outlet pair of a further multi-product suite and an inlet/outlet pair is configured to be sealed when the connection to the further inlet/outlet pair is discontinued.

4. The volume tailorable manufacturing system of claim 1 , wherein first and second multi-product suites are comprised in the volume tailorable manufacturing system, an inlet/outlet pair of the first multiproduct suite is connected to an inlet/outlet pair of the second multiproduct suite, and the control facility is configured to control a unidirectional flow in a circulation system interconnecting the first and second multi-product suites.

5. The volume tailorable manufacturing system of claim 1 , wherein the return system of each multi-product suite is configured as a passage along a perimeter of the volume tailorable manufacturing system.

6. The volume tailorable manufacturing system of claim 1 , wherein each multi-product suite of the one or more multi-product suites comprises a first communication interface to the supply system and a second communication interface to the return system.

7. The volume tailorable manufacturing system of claim 2 , wherein the biosafety level classification is BioSafetyLevel 2, BSL2, and wherein the connection is validated prior to breaking the seal.

8. The volume tailorable manufacturing system of claim 1 , wherein the one or more multi-product suites are micro modules configured for biopharmaceutical manufacturing, and wherein the separated supply and return systems are connected to a macrostructure comprising a hydration facility and warehouse facility.

9. The volume tailorable manufacturing system of claim 6 , wherein the first communication interface comprises a materials delivery interface and the second communication interface comprises a product delivery interface.

10. The volume tailorable manufacturing system of claim 9 , wherein the materials delivery interface and the product delivery interface are provided by means of air locks.

11. The volume tailorable manufacturing system of claim 9 , wherein the materials delivery comprises supply material delivered to a designated multi-product suite in single-use equipment, the supply material comprising customized culture media and/or buffer.

12. The volume tailorable manufacturing system of claim 1 , wherein the one or more multi-product suites are arranged to receive materials delivery of single-use product contact components.

13. The volume tailorable manufacturing system of claim 6 , wherein each multi-product suite of the one or more multi-product suites comprises at least one further communication interface controlled by a control unit in the respective multi-product suite and wherein the at least one further communications interface is arranged to control employee access to/from the respective multi-product suite.

14. A method for expanding production volume capability of a manufacturing system for quality assured manufacturing of biopharmaceutical products associated with a biosafety level classification, the manufacturing system comprising a first multi-product suite and a control facility configured to control a unidirectional flow in a circulation system of the first multi-product suite; wherein the circulation system comprises separated supply and return systems, the supply system comprising an inlet, the return system comprising an outlet that is paired with the inlet, the method comprising

arranging a second multi-product suite in a position adjacent to the first multi-product suite so that a position of an inlet/outlet pair of the second multi-product suite is arranged to mirror the position of an inlet/outlet pair of the first multi-product suite;

interconnecting the inlet/outlet pair of the first multi-product suite with the inlet/outlet pair of the second multi-product suite; and

breaking a seal of each inlet/outlet pair, and

wherein the supply system is configured as a central spine within a center portion of the manufacturing system and being at least partly enclosed by the first or second multi-product suites.

15. The method of claim 14 , wherein the interconnecting comprises validating that a connection formed between the inlet/outlet pair of the first multi-product suite and the inlet/outlet pair of the second multi-product suite complies with requirements for quality assured manufacturing of BioSafetyLevel 2, BSL2, classified biopharmaceutical products and breaking the seal following such validation.

16. The method of claim 14 , wherein the quality assured manufacturing of the biopharmaceutical products associated with a biosafety level classification has been validated for each of the first and second multi-product suites and includes validation of respective inlet/outlet pairs, wherein validation of the second multi-product suite is uncorrelated to validation of the first multi-product suite and wherein the validation of respective inlet/outlet pairs comprises pre-validating a connection to be formed.

17. A method for decreasing production volume capability of a manufacturing system for quality assured manufacturing of biopharmaceutical products associated with a biosafety level classification, the manufacturing system comprising two or more multi-product suites and a control facility configured to control a unidirectional flow in a circulation system of the two or more multi-product suites; wherein the circulation system is configured to interconnect the two or more multi-product suites and wherein the circulation system comprises separated supply and return systems and wherein each multi-product suite of the two or more multi-product suites comprises at least one inlet to the supply system and at least one outlet from the return system, wherein the outlet is paired with the inlet and provided at a spatially predetermined position from the inlet, and the two or more multi-product suites are arranged in adjacent positions having the an inlet/outlet pair of a first multi-product suite of the two or more multi-product suites interconnected with an inlet/outlet pair of a second multi-product suite of the two or more multi-product suites; the method comprising:

disconnecting the first and second multi-product suites by sealing the inlet/outlet pair of the first multi-product suite and/or the second multi-product suite; and

adapting the control facility to control a unidirectional flow in the first multi-product suite, and

wherein the supply system is configured as a central spine within a center portion of the manufacturing system and being at least partly enclosed by the first or second multi-product suites.

18. The method of claim 17 , further comprising distancing the second multi-product suite from the first multi-product suite by physically relocating the second multi-product suite to a new location.